rxstatShortages › Calcipotriol Betamethasone

Calcipotriol Betamethasone (Dovobet) shortage status

Partial shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Some Calcipotriol Betamethasone products are in shortage in Canada (1 of 3 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer.

A topical combination of a vitamin D analog and a steroid used to treat psoriasis.

Products affected
1 / 3
In shortage since
Oct 8, 2025
Reports on file
16
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Book a pharmacist appointment
Need your prescription switched?
If your product stays unavailable, an online doctor can assess your situation and prescribe an alternative.
See a doctor online

Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.

Shortage history

2023 2024 2025 2026

Shortage history (red bands = periods in shortage).

Reports by product

The DIN is printed on your prescription label.

Active shortage
TEVA-BETAMETHASONE/ CALCIPOTRIOL
50MCG 0.5MG · OINTMENT · TEVA CANADA LIMITED
DIN 02427419 · since Dec 3, 2025, est. end Jul 10, 2026 · Disruption of the manufacture of the drug.
Active shortage
TEVA-BETAMETHASONE/ CALCIPOTRIOL
0.5MG 50MCG · OINTMENT · TEVA CANADA LIMITED
DIN 02427419 · since Oct 8, 2025, est. end Jul 10, 2026 · Disruption of the manufacture of the drug.
Resolved
TARO-CALCIPOTRIOL / BETAMETHASONE GEL
0.5MG 50MCG · GEL · TARO PHARMACEUTICALS INC
DIN 02525178 · ended Feb 20, 2026 · Disruption of the manufacture of the drug.
Resolved
TARO-CALCIPOTRIOL / BETAMETHASONE GEL
0.5MG 50MCG · GEL · TARO PHARMACEUTICALS INC
DIN 02525178 · ended Dec 17, 2025 · Disruption of the manufacture of the drug.
Resolved
TARO-CALCIPOTRIOL / BETAMETHASONE GEL
0.5MG 50MCG · GEL · TARO PHARMACEUTICALS INC
DIN 02525178 · ended Dec 9, 2025 · Disruption of the manufacture of the drug.
Resolved
TARO-CALCIPOTRIOL / BETAMETHASONE GEL
0.5MG 50MCG · GEL · TARO PHARMACEUTICALS INC
DIN 02525178 · ended Nov 10, 2025 · Disruption of the manufacture of the drug.
Resolved
TEVA-BETAMETHASONE/ CALCIPOTRIOL
0.5MG 50MCG · OINTMENT · TEVA CANADA LIMITED
DIN 02427419 · ended Sep 8, 2025 · Disruption of the manufacture of the drug.
Resolved
TEVA-BETAMETHASONE/ CALCIPOTRIOL
50MCG 0.5MG · OINTMENT · TEVA CANADA LIMITED
DIN 02427419 · ended Jun 18, 2025 · Disruption of the manufacture of the drug.
Resolved
TARO-CALCIPOTRIOL / BETAMETHASONE GEL
0.5MG 50MCG · GEL · TARO PHARMACEUTICALS INC
DIN 02525178 · ended Mar 8, 2024 · Disruption of the manufacture of the drug.
Resolved
TARO-CALCIPOTRIOL / BETAMETHASONE GEL
0.5MG 50MCG · GEL · TARO PHARMACEUTICALS INC
DIN 02525178 · ended Jul 18, 2023 · Disruption of the manufacture of the drug.
Resolved
TARO-CALCIPOTRIOL / BETAMETHASONE GEL
0.5MG 50MCG · GEL · TARO PHARMACEUTICALS INC
DIN 02525178 · ended Jul 18, 2023 · Disruption of the manufacture of the drug.
Resolved
TEVA-BETAMETHASONE/ CALCIPOTRIOL
50MCG 0.5MG · OINTMENT · TEVA CANADA LIMITED
DIN 02427419 · ended Jul 5, 2023 · Disruption of the manufacture of the drug.

Showing 12 of 16 reports. All reports are on file with Health Canada.

What's happening

Calcipotriol Betamethasone is currently affected by an active shortage report filed with Health Canada by TEVA CANADA LIMITED.

The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Calcipotriol Betamethasone is classified under “CORTICOSTEROIDS, OTHER COMBINATIONS” (ATC D07XC).

Recent changes

Common questions

What is Calcipotriol Betamethasone used for?

A topical combination of a vitamin D analog and a steroid used to treat psoriasis.

When will Calcipotriol Betamethasone be back in stock in Canada?

Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.

Why is Calcipotriol Betamethasone in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Possible alternatives in the same class (corticosteroids, other combinations)

Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.